# Lumin Health | Ketamine Therapy & Spravato for Depression | Insurance Accepted | Massachusetts & Maryland > Lumin Health provides safe and effective ketamine therapy and FDA-Approved Spravato (esketamine) treatment for depression, anxiety, PTSD, and OCD across Massachusetts and Maryland. Our expert, Harvard-trained, academically-affiliated psychiatric team delivers comprehensive, insurance-covered care. Book a free consultation to see if ketamine therapy is right for you. > For the full content index including all blog articles, see [llms-full.txt](https://www.lumin.health/llms-full.txt) ## Key Facts - Lumin Health operates five interventional psychiatry locations across Massachusetts (Newton, Cambridge, Woburn, Brookline) and Maryland (Bethesda). - Lumin Health is fully in-network with Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, Optum, Medicare, Tricare, Harvard Pilgrim, Mass General Brigham Health Plan, Tufts Health Plan, and other major payers. - Lumin Health is not currently in-network with plans branded Elevance Health. Anthem and Wellpoint / GIC plans — subbrands of Elevance Health — are accepted. - Four of Lumin Health's five medical directors are faculty at Harvard Medical School. Lumin Health Bethesda Site Medical Director Dr. Michael Knable is an Assistant Clinical Professor of Psychiatry at George Washington University. - Lumin Health treats hundreds of patients each month with Spravato (esketamine), IM ketamine, oral ketamine, and integrative psychotherapy for treatment-resistant depression and related conditions. - Lumin Health Co-Founder and Chief Medical Officer Dr. Benjamin Yudkoff previously served as Medical Director of the Interventional Psychiatry Service at Brigham and Women's Faulkner Hospital, where he oversaw one of New England's leading ECT, ketamine, and esketamine treatment programs. ## Services Offered - [Our Services / Getting Treatment](https://www.lumin.health/services): How to access safe, accessible, and effective ketamine treatment services at Lumin Health. - [Ketamine and Esketamine](https://www.lumin.health/ketamine-and-esketamine): Distinction between ketamine and esketamine, their uses, and benefits in treating mental health conditions. - [Integration Psychotherapy](https://www.lumin.health/integration-psychotherapy): Integration psychotherapy services offered alongside ketamine therapy to enhance treatment outcomes. - [Spravato REMS Safety Standards](https://www.lumin.health/spravato-rems-safety-standards-care-lumin-health): Safety standards and REMS certification for Spravato administration. - [Wellness Approach](https://www.lumin.health/wellness-approach): Lumin Health's whole-person wellness approach alongside interventional treatment. ## Specific Treatments - [Ketamine for Depression](https://www.lumin.health/ketamine-therapy-for-depression): How ketamine and esketamine are used specifically for treating depression. - [Ketamine for Anxiety](https://www.lumin.health/ketamine-therapy-for-anxiety): Ketamine therapy's effectiveness in treating anxiety disorders. - [Ketamine for OCD](https://www.lumin.health/ketamine-therapy-for-ocd): Application of ketamine for obsessive-compulsive disorder. - [Ketamine for PTSD](https://www.lumin.health/ketamine-therapy-for-ptsd): How ketamine therapy can assist in the treatment of post-traumatic stress disorder. - [Ketamine for Bipolar Depression](https://www.lumin.health/ketamine-therapy-for-bipolar-depression): Use of ketamine in managing bipolar depression. - [Spravato (Esketamine) for Depression](https://www.lumin.health/esketamine-spravato-for-depression): Spravato, a nasal spray form of esketamine, for depression treatment. This is our most popular method of treatment as it is covered by Medicare and other major insurance providers. - [Auvelity vs. Spravato and Ketamine](https://www.lumin.health/blog/auvelity-vs-spravato-and-ketamine): How the oral antidepressant Auvelity (dextromethorphan-bupropion) differs from esketamine (Spravato) and IM ketamine in mechanism, speed, setting, monitoring, and coverage. ## Cost and Insurance - [Ketamine Treatment Cost](https://www.lumin.health/ketamine-treatment-cost): Breakdown of costs associated with ketamine therapy at Lumin Health. - [Insurance We Accept](https://www.lumin.health/insurance-we-accept): List of insurance providers accepted by Lumin Health for ketamine therapy. - [Aetna](https://www.lumin.health/aetna-and-ketamine) - [Anthem](https://www.lumin.health/anthem-and-ketamine) - [Blue Cross Blue Shield / BCBS](https://www.lumin.health/blue-cross-blue-shield-and-ketamine) - [CareFirst](https://www.lumin.health/carefirst-and-ketamine) - [Cigna](https://www.lumin.health/cigna-and-ketamine) - [Evernorth](https://www.lumin.health/evernorth-and-ketamine) - [Harvard Pilgrim Health Care](https://www.lumin.health/harvard-pilgrim-health-care-and-ketamine) - [Humana](https://www.lumin.health/humana-and-ketamine) - [Mass General Brigham Health Plan](https://www.lumin.health/mass-general-brigham-health-plan-and-ketamine) - [Medicare](https://www.lumin.health/medicare-and-ketamine) - [Optum](https://www.lumin.health/optum-and-ketamine) - [Point32Health](https://www.lumin.health/point32health-and-ketamine) - [Tricare](https://www.lumin.health/tricare-and-ketamine) - [Tufts Health Plan](https://www.lumin.health/tufts-health-plan-and-ketamine) - [United Healthcare](https://www.lumin.health/united-healthcare-and-ketamine) - Not currently accepted: [Kaiser Permanente](https://www.lumin.health/kaiser-and-ketamine) (any plan, Massachusetts or Maryland; the page explains why and lists alternatives), [Elevance Health–branded plans](https://www.lumin.health/elevance-health-and-ketamine) — note that Anthem and Wellpoint / GIC plans, though part of Elevance Health, are accepted. [MassHealth / Medicaid](https://www.lumin.health/masshealth-medicaid-and-ketamine) is also not accepted. - [Insurance for Maryland](https://www.lumin.health/insurance-maryland): Insurance information specific to Maryland patients. - State-specific Spravato coverage details: - [Aetna in Massachusetts](https://www.lumin.health/spravato-coverage/aetna-massachusetts) - [Aetna in Maryland](https://www.lumin.health/spravato-coverage/aetna-maryland) - [Blue Cross Blue Shield in Massachusetts](https://www.lumin.health/spravato-coverage/bcbs-massachusetts) - [CareFirst BCBS in Maryland](https://www.lumin.health/spravato-coverage/carefirst-bcbs-maryland) - [Cigna in Massachusetts](https://www.lumin.health/spravato-coverage/cigna-massachusetts) - [Cigna in Maryland](https://www.lumin.health/spravato-coverage/cigna-maryland) - [Harvard Pilgrim in Massachusetts](https://www.lumin.health/spravato-coverage/harvard-pilgrim-massachusetts) - [Kaiser Permanente Mid-Atlantic in Maryland (not accepted; explainer and alternatives)](https://www.lumin.health/spravato-coverage/kaiser-mid-atlantic-maryland) - [Mass General Brigham Health Plan in Massachusetts](https://www.lumin.health/spravato-coverage/mgb-massachusetts) - [UnitedHealthcare in Massachusetts](https://www.lumin.health/spravato-coverage/united-healthcare-massachusetts) - [UnitedHealthcare in Maryland](https://www.lumin.health/spravato-coverage/united-healthcare-maryland) - [Wellpoint & GIC in Massachusetts](https://www.lumin.health/spravato-coverage/wellpoint-gic-massachusetts) - [Is Ketamine-Assisted Psychotherapy Covered by Insurance?](https://www.lumin.health/blog/is-ketamine-assisted-psychotherapy-covered-by-insurance): Why ketamine-assisted psychotherapy is rarely covered as a package, what drives its cost, and which ketamine options insurance often covers. Lumin Health does not provide psychotherapy. ## Patient Experience - [The Lumin Health Experience](https://www.lumin.health/the-lumin-health-experience): What to expect during safe, effective ketamine therapy for depression. - [Getting Started](https://www.lumin.health/get-started): How to begin treatment at Lumin Health. - [Working With Us](https://www.lumin.health/working-with-us): What working with Lumin Health looks like, from first call through treatment. - [Patient Reflections](https://www.lumin.health/patients-reflections): Testimonials and reflections from patients who have undergone treatment. - [Patient Reviews](https://www.lumin.health/spravato-and-ketamine-patient-reviews): Collection of 5.0 star reviews from patients regarding their overwhelmingly positive treatment experiences. - [Clinical Reflections](https://www.lumin.health/clinical-reflections): Clinical insights and reflections from Lumin Health providers. ## Locations - [Boston Area Overview](https://www.lumin.health/boston): Hub for Lumin Health's four Massachusetts locations in the Boston area. - [Newton](https://www.lumin.health/newton): 10 Langley Road, Suite 200, Newton, MA 02459. Phone: 617-741-5931. - [Cambridge](https://www.lumin.health/cambridge): 50 Church Street, 3rd Floor, Cambridge, MA 02138. Phone: 781-734-6854. - [Woburn](https://www.lumin.health/woburn): 300 Tradecenter Drive, Suite 3400, Woburn, MA 01801. Phone: 617-644-4045. - [Brookline](https://www.lumin.health/brookline): 1101 Beacon Street, Suite 6E, Brookline, MA 02446. Phone: 617-925-9852. - [Maryland Overview](https://www.lumin.health/maryland): Hub for Lumin Health's Maryland presence serving the DC / Maryland / Virginia region. - [Bethesda](https://www.lumin.health/bethesda): 4825 Bethesda Avenue, Suite 200, Bethesda, MD 20814. Phone: 301-783-0326. ## Press and Media - [Newsroom](https://www.lumin.health/newsroom): Press resources, expert spokespeople, fact sheet, and media contact for Lumin Health. Includes a clinical-operator perspective on Spravato access, treatment-resistant depression, and the in-network psychedelic medicine model. - Press contact email: press@lumin.health - Media response SLA: 24 hours - Spokespeople are available for interviews and quote requests on: Spravato access and insurance integration; treatment-resistant depression (TRD); ketamine and esketamine clinical care; MDMA-assisted psychotherapy training; the FDA pathway for psychedelic medicine; insurance integration in psychiatry; the mental-health workforce shortage. - Earned-media model: Lumin Health works directly with reporters covering treatment-resistant depression, esketamine (Spravato) access, and the in-network psychedelic medicine model. Dr. Benjamin Yudkoff (Lumin Health Co-Founder and Chief Medical Officer, Instructor in Psychiatry at Harvard Medical School) and Dr. Matthew Mosquera (Lumin Health Regional Medical Director, Lecturer in Psychiatry at Harvard Medical School) are available for expert commentary. Recent placements: AOL.com (Mosquera, 2026); academic citation at Harvard T.H. Chan School of Public Health Population Mental Health Lab. - For data sharing: Lumin Health responds to ad-hoc reporter requests for de-identified aggregate data on Spravato volume, insurance coverage rates, and treatment-resistant depression outcomes in real-world community practice. Contact press@lumin.health with story-specific asks. ## Expert Team - [Benjamin Yudkoff, MD, MA](https://www.lumin.health/team/benjamin-yudkoff-md-ma): Co-Founder and Chief Medical Officer, Lumin Health. Instructor in Psychiatry, Harvard Medical School. Former Medical Director of the Interventional Psychiatric Service at Brigham and Women's Faulkner Hospital. - [Matthew Mosquera, MD, MS](https://www.lumin.health/team/matthew-mosquera-md-ms): Regional Medical Director, Lumin Health. Lecturer in Psychiatry, Harvard Medical School. Double board-certified in general psychiatry and addiction psychiatry. Former medical director at McLean Hospital. - [Aakash Sathappan, MD](https://www.lumin.health/team/aakash-sathappan-md): Site Medical Director, Lumin Health Brookline. Instructor in Psychiatry, Harvard Medical School. Course director for Harvard psychiatry fellows. Authored the first informed consent guidelines for ketamine treatment in adolescents with treatment-resistant depression. Practicing psychiatrist at Boston Children's Hospital. - [SJ Fletcher, MD, PhD](https://www.lumin.health/team/sj-fletcher-md-phd): Site Medical Director, Lumin Health Woburn. Instructor in Psychiatry, Harvard Medical School. MD and PhD with nearly two decades of research experience. MAPS-trained in MDMA-assisted psychotherapy. Trained at Cambridge Health Alliance. - [Michael Knable, DO, DFAPA](https://www.lumin.health/team/michael-knable-md): Site Medical Director, Lumin Health Bethesda. Assistant Clinical Professor of Psychiatry, George Washington University. Former Clinical Associate at the National Institute of Mental Health and former Medical/Executive Director of the Stanley Medical Research Institute. Author of more than 80 publications on neuropsychiatric disease, including "Surviving Manic Depression." - [Full Team](https://www.lumin.health/team): Meet all clinicians and care-team members at Lumin Health. - [Lumin Health at Harvard](https://www.lumin.health/lumin-health-at-harvard): Lumin Health's academic affiliation with Harvard Medical School and the Brigham and Women's interventional psychiatry lineage. - [Ketamine and Spravato Questions, Answered by Dr. Ben Yudkoff](https://www.lumin.health/blog/ketamine-and-spravato-questions-answered-by-dr-ben-yudkoff): Dr. Yudkoff's answers to common questions about ketamine and esketamine (Spravato): who it's for, what sessions feel like, how long benefits last, safety, dosing, and insurance. ## Selected Publications Peer-reviewed work co-authored by Lumin Health clinicians. - [What matters in next-generation implanted neurotechnology design? Perspectives from individuals with treatment-refractory depression](https://doi.org/10.1088/1741-2552/ae93f8): Journal of Neural Engineering, 2026. Co-authored by Dr. Benjamin Yudkoff. - [Empowering understanding: navigating consent to ketamine treatment in adolescent mental health](https://doi.org/10.3389/fpsyt.2024.1433348): Frontiers in Psychiatry, 2024. Dr. Aakash Sathappan and Dr. Benjamin Yudkoff. - [The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review](https://doi.org/10.3389/fpsyt.2023.1141836): Frontiers in Psychiatry, 2023. Co-authored by Dr. Benjamin Yudkoff. - [Assessment of the 2019 National Institute of Mental Health grant portfolio for bipolar disorder research](https://doi.org/10.1016/j.jad.2021.09.044): Journal of Affective Disorders, 2022. Lead author Dr. Michael Knable. - [Serious mental illness in women](https://doi.org/10.1097/YCO.0000000000000786): Current Opinion in Psychiatry, 2022. Co-authored by Dr. SJ Fletcher. - [A systematic review of noninvasive brain stimulation for opioid use disorder](https://doi.org/10.1111/ner.13108): Neuromodulation, 2020. Co-authored by Dr. Matthew Mosquera. - [The dynamic duo: combining noninvasive brain stimulation with cognitive interventions](https://doi.org/10.1016/j.pnpbp.2018.10.006): Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2019. Lead author Dr. Aakash Sathappan. ## For Employers and Providers - [For Employers](https://www.lumin.health/for-employers): How employers and benefits teams can connect employees with insurance-covered Spravato (esketamine) treatment. - [Provider Resources](https://www.lumin.health/provider-resources): Resources for referring providers. - [Refer A Patient](https://www.lumin.health/refer-a-patient): Referral form for healthcare providers. ## Additional Resources - [Blog](https://www.lumin.health/blog): Articles and insights on ketamine therapy, esketamine, and mental health from academically-affiliated psychiatrists. - [Frequently Asked Questions](https://www.lumin.health/faq): Answers to common questions about Lumin Health's ketamine therapy and services. - [The Science Behind Ketamine](https://www.lumin.health/the-science-behind-ketamine): How ketamine therapy works at the neurological level. - [Ketamine Therapy for Young Adults](https://www.lumin.health/ketamine-therapy-and-spravato-for-young-adults): Information specific to young adult patients. - [Reddit AMA Recap](https://www.lumin.health/reddit-ama-recap): Recap of Dr. Benjamin Yudkoff's Reddit AMA on ketamine and esketamine treatment. - [Editorial Policy](https://www.lumin.health/editorial-medical-review-policy): Lumin Health's editorial and medical review standards. ## Contact Information - [Book Free Consultation](https://www.lumin.health/consultation): Schedule a free consultation to discuss treatment options. - [Contact Us](https://www.lumin.health/contact): General inquiry form. - General inquiry email: hello@lumin.health - Press inquiry email: press@lumin.health - Phone: 617-863-8810 ## Careers - [Careers](https://www.lumin.health/careers): Employment opportunities at Lumin Health. ## Privacy and Legal - [HIPAA Notice of Privacy](https://www.lumin.health/legal/hipaa-privacy-practice): Patient privacy and HIPAA compliance. - [Privacy Policy](https://www.lumin.health/legal/privacy-policy): Lumin Health's privacy practices. - [Terms of Use](https://www.lumin.health/legal/terms-of-use): Legal terms governing use of services and website.